QUINAZOLIN-2-ONES HAVING A SPIROHYDANTOIN RING .1. SYNTHESIS OF SPIRO[1,2,3,4-TETRAHYDROQUINAZOLINE-4,4'-IMIDAZOLIDINE]-2,2',5'-TRIONE BY REACTION OF 1-CARBAMOYLISATIN WITH UREA OR GUANIDINE

被引:8
作者
YAMAGISHI, M [1 ]
OZAKI, K [1 ]
OHMIZU, H [1 ]
YAMADA, Y [1 ]
SUZUKI, M [1 ]
机构
[1] TANABE SEIYAKU CO LTD, APPL BIOCHEM RES LAB, 16-89 KASHIMA 3 CHOME, YODOGAWA KU, OSAKA 532, JAPAN
关键词
2'; 2,3; 4'-imidazolidine]-2; 4-tetrahydroquinazolin-2; 5'-trione 1-methylcarbamoylisatin urea guanidine intramolecular cyclization 4-hydroxy-1; one spirohydantoin spiro[l,2,3,4-tetrahydroquinazoline-4;
D O I
10.1248/cpb.38.2926
中图分类号
R914 [药物化学];
学科分类号
100701 [药物化学];
摘要
Reaction of 1-methylcarbamoylisatin (4) with urea in the presence of l,8-diazabicyclo[5.4.0]undec-7-ene (DBU) gave 4-hydroxy-3-methyl-4-ureidocarbonyl-l,2,3,4-tetrahydroquinazolin-2-one (5), which was easily cyclized with 10% HC1 to afford a spirohydantoin derivative; 3-methyl-spiro [1,2,3,4-tetrahydroquinazoline-4,4'-imidazolidine] -2,2’,5 - trione (6). In a similar manner, 2/-imino-3-methyl-spiro[l,2,3,4-tetrahydroquinazoline-4,4'-imidazolidine]-2,5’-dione (8) was prepared by the reaction of 4 with guanidine, and 8 was further converted to the spirohydantoin compound 6 by treatment with sodium nitrite in acetic acid. © 1990, The Pharmaceutical Society of Japan. All rights reserved.
引用
收藏
页码:2926 / 2928
页数:3
相关论文
共 10 条
[1]
HETEROCYCLIZATIONS .7. NEW HYDANTOINS WITH BRIDGE-HEAD NITROGEN OR SPIRAN STRUCTURE [J].
CAPUANO, L ;
WELTER, M ;
ZANDER, R .
CHEMISCHE BERICHTE-RECUEIL, 1970, 103 (08) :2394-&
[2]
RING TRANSFORMATIONS IN ISATINE SERIES .4. SPIROCYCLIZATIONS [J].
CAPUANO, L ;
BENZ, K .
CHEMISCHE BERICHTE-RECUEIL, 1977, 110 (12) :3849-3861
[3]
PHENYNLDIAZOMETHANE AND TRIETHYLAMINE AS CYCLIZING AGENTS .3. SYNTHESIS OF IMIDAZO(1.5-A)INDOLES PYRROLO(1.2-C)IMIDAZOLES AND QUINAZOLINES [J].
CAPUANO, L ;
WELTER, M .
CHEMISCHE BERICHTE-RECUEIL, 1968, 101 (11) :3671-&
[4]
ALDOSE REDUCTASE INHIBITORS - A POTENTIAL NEW CLASS OF AGENTS FOR THE PHARMACOLOGICAL CONTROL OF CERTAIN DIABETIC COMPLICATIONS [J].
KADOR, PF ;
KINOSHITA, JH ;
SHARPLESS, NE .
JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (07) :841-849
[5]
QUINAZOLINES AND 1,4-BENZODIAZEPINES .28. SUBSTITUTED 2(3H)-QUINAZOLINONES AND -QUINAZOLINETHIONES [J].
METLESICS, W ;
SILVERMAN, G ;
TOOME, V ;
STERNBACH, LH .
JOURNAL OF ORGANIC CHEMISTRY, 1966, 31 (04) :1007-+
[6]
PETERSEN S, 1974, LIEBIGS ANN CHEM, V12, P2003
[7]
SAKAMOTO N, 1983, FARUMASHIA, V19, P43
[8]
TANI J, 1979, CHEM PHARM BULL, V27, P2675
[9]
STUDIES ON BIOLOGICALLY-ACTIVE HALOGENATED COMPOUNDS .1. SYNTHESIS AND CENTRAL NERVOUS-SYSTEM DEPRESSANT ACTIVITY OF 2-(FLUOROMETHYL)-3-ARYL-4(3H)-QUINAZOLINONE DERIVATIVES [J].
TANI, J ;
YAMADA, Y ;
OINE, T ;
OCHIAI, T ;
ISHIDA, R ;
INOUE, I .
JOURNAL OF MEDICINAL CHEMISTRY, 1979, 22 (01) :95-99
[10]
TANIMOTO T, 1988, FARUMASHIA, V24, P459